SG Americas Securities LLC Purchases 4,342 Shares of Definitive Healthcare Corp. (NASDAQ:DH)

SG Americas Securities LLC increased its position in Definitive Healthcare Corp. (NASDAQ:DH) by 30.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 18,802 shares of the company’s stock after acquiring an additional 4,342 shares during the quarter. SG Americas Securities LLC’s holdings in Definitive Healthcare were worth $187,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of DH. Global Retirement Partners LLC raised its holdings in Definitive Healthcare by 86.0% in the 3rd quarter. Global Retirement Partners LLC now owns 4,171 shares of the company’s stock worth $31,000 after acquiring an additional 1,928 shares during the period. Ameritas Investment Partners Inc. bought a new position in Definitive Healthcare in the 2nd quarter worth $41,000. Ensign Peak Advisors Inc bought a new position in Definitive Healthcare in the 3rd quarter worth $53,000. PNC Financial Services Group Inc. raised its holdings in Definitive Healthcare by 34.6% in the 4th quarter. PNC Financial Services Group Inc. now owns 5,092 shares of the company’s stock worth $56,000 after acquiring an additional 1,309 shares during the period. Finally, Tower Research Capital LLC TRC raised its holdings in Definitive Healthcare by 223.1% in the 3rd quarter. Tower Research Capital LLC TRC now owns 5,710 shares of the company’s stock worth $89,000 after acquiring an additional 3,943 shares during the period. Institutional investors own 98.67% of the company’s stock.

Definitive Healthcare Price Performance

Shares of DH stock opened at $7.35 on Friday. Definitive Healthcare Corp. has a 1 year low of $5.53 and a 1 year high of $12.45. The firm’s 50 day moving average is $8.53 and its 200-day moving average is $8.33. The firm has a market capitalization of $865.75 million, a price-to-earnings ratio of -4.13, a PEG ratio of 11.38 and a beta of 1.39. The company has a current ratio of 2.31, a quick ratio of 2.31 and a debt-to-equity ratio of 0.20.

Definitive Healthcare (NASDAQ:DH) last announced its earnings results on Wednesday, February 28th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.02). Definitive Healthcare had a positive return on equity of 0.43% and a negative net margin of 80.40%. The company had revenue of $65.93 million for the quarter, compared to analyst estimates of $66.01 million. Sell-side analysts forecast that Definitive Healthcare Corp. will post 0.07 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages recently commented on DH. Barclays lifted their target price on shares of Definitive Healthcare from $10.00 to $11.00 and gave the stock an “equal weight” rating in a report on Friday, March 1st. Canaccord Genuity Group boosted their price objective on shares of Definitive Healthcare from $9.00 to $10.00 and gave the stock a “hold” rating in a report on Thursday, February 29th. Needham & Company LLC downgraded shares of Definitive Healthcare from a “buy” rating to a “hold” rating in a report on Wednesday, January 17th. Canaccord Genuity Group downgraded shares of Definitive Healthcare from a “buy” rating to a “hold” rating in a report on Friday, January 5th. Finally, Stifel Nicolaus dropped their price objective on shares of Definitive Healthcare from $12.00 to $11.00 and set a “buy” rating on the stock in a report on Wednesday, January 17th. Seven research analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, Definitive Healthcare presently has a consensus rating of “Hold” and an average price target of $11.31.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.